Funding Intelligence

Oxford Quantum Circuits Secures $260 Million in Latest Series C Funding Round

Funding Intelligence Staff · · 2 min read

Oxford Quantum Circuits secured $260 million in its latest Series C, adding another data point to the Healthcare & Life Sciences funding market.

Series C$260 millionHealthcare & Life Sciencesundisclosed headquarters

Oxford Quantum Circuits Raises $260 million in Funding

Oxford Quantum Circuits is a Digital Health company focused on scale globally competitive deep tech companies.

Investors Behind the Funding

The round was backed by Bullhound Capital. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Oxford Quantum Circuits operates in Healthcare & Life Sciences. Oxford Quantum Circuits's Series C round shows investors are still backing digital health platforms with real scale narratives. At $260M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

scale globally competitive deep tech companies

Looking Ahead

Oxford Quantum Circuits lands "coming-of-age" £260M funding round

Source reference: original announcement/article.

View Oxford Quantum Circuits's full profile and funding history on Funding Intelligence →